Underdiagnosis of Attention-Deficit/Hyperactivity Disorder in Adult Patients: A Review of the Literature

por Ginsberg, Ylva, Quintero, Javier, Anand, Ernie, Casillas, Marta, Upadhyaya, Himanshu P.
Publicado 2014

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

por Upadhyaya, Himanshu P., Arnold, Lesley M., Alaka, Karla, Qiao, Meihua, Williams, David, Mehta, Renata
Publicado 2019

Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: results from a large observational study

por Meyers, Kristin J., Upadhyaya, Himanshu P., Landry, John L., Chhabra-Khanna, Rashna, Falk, Deborah M., Seetharama Rao, Balasubramanya, Jones, Meghan E.
Publicado 2017

Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study

por Huybrechts, Krista F, Bateman, Brian T, Pawar, Ajinkya, Bessette, Lily G, Mogun, Helen, Levin, Raisa, Li, Hu, Motsko, Stephen, Scantamburlo Fernandes, Maria Fernanda, Upadhyaya, Himanshu P, Hernandez-Diaz, Sonia
Publicado 2020

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

por Upadhyaya, Himanshu P., Desaiah, Durisala, Schuh, Kory J., Bymaster, Frank P., Kallman, Mary J., Clarke, David O., Durell, Todd M., Trzepacz, Paula T., Calligaro, David O., Nisenbaum, Eric S., Emmerson, Paul J., Schuh, Leslie M., Bickel, Warren K., Allen, Albert J.
Publicado 2013

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

por Upadhyaya, Himanshu P., Chien, Jenny Y., Long, Amanda J., Bohm, Martin S., Kallewaard, Nicole L., Macpherson, Lisa F., Patel, Dipak R., Hufford, Matthew M., Krull, Constance J., Ang, Jocelyn Y., Chen, Peter, Muller, William J., Potts, Jeffrey A., Quinn, Timothy, Williams, Mark
Publicado 2023